Stoke Therapeutics, Inc.
STOK
31 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Mar 17 9:23 PM | LEVIN ARTHUR ADirector | Sale | 605 | $36.80 | $22.3K | 4,237(D) | View → |
| Mar 13, 2026 | Mar 13 8:19 PM | ARTHUR A LEVIN | Proposed Sale | 605 | $36.48 | $22.1K | — | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Sale | 4,355 | $40.00 | $174.2K | 31,339(D) | View → |
| Mar 10, 2026 | Mar 12 8:56 PM | Adrian R. KrainerDirector | Sale | 33,243 | $39.74 | $1.3M | 283,302(D) | View → |
| Mar 10, 2026 | Mar 10 8:39 PM | ARTHUR TZIANABOS | Proposed Sale | 90,508 | $38.31 | $3.5M | — | View → |
| Mar 2, 2026 | Mar 4 9:28 PM | Adrian R. KrainerDirector | Sale | 7,229 | $39.66 | $286.7K | 316,545(D) | View → |
| Mar 2, 2026 | Mar 2 9:42 PM | Adrian Krainer | Proposed Sale | 40,472 | $36.41 | $1.5M | — | View → |
| Dec 8, 2025 | Dec 8 9:40 PM | EDWARD M KAYE | Proposed Sale | 13,430 | $30.87 | $414.6K | — | View → |
| Dec 8, 2025 | Dec 8 9:38 PM | JONATHAN ALLAN | Proposed Sale | 3,978 | $30.87 | $122.8K | — | View → |
| Dec 5, 2025 | Dec 5 9:38 PM | EDWARD M KAYE | Proposed Sale | 2,181 | $31.05 | $67.7K | — | View → |
| Dec 5, 2025 | Dec 5 9:29 PM | JONATHAN ALLAN | Proposed Sale | 7,781 | $31.05 | $241.6K | — | View → |
| Dec 5, 2025 | Dec 5 9:29 PM | BARUCH TICHO | Proposed Sale | 1,989 | $31.05 | $61.8K | — | View → |
| Nov 24, 2025 | Nov 24 9:24 PM | Adrian Krainer | Proposed Sale | 40,472 | $29.34 | $1.2M | — | View → |
| Nov 14, 2025 | Nov 14 9:29 PM | Adrian Krainer | Proposed Sale | 40,472 | $26.07 | $1.1M | — | View → |
| Nov 3, 2025 | Nov 3 9:22 PM | BARUCH TICHO | Proposed Sale | 5,931 | $30.04 | $178.2K | — | View → |
| Oct 8, 2025 | Oct 8 8:20 PM | EDWARD M KAYE | Proposed Sale | 25,000 | $27.31 | $682.8K | — | View → |
| Oct 3, 2025 | Oct 3 8:35 PM | EDWARD M KAYE | Proposed Sale | 42,461 | $24.82 | $1.1M | — | View → |
| Oct 3, 2025 | Oct 3 8:30 PM | JONATHAN ALLAN | Proposed Sale | 10,000 | $24.82 | $248.2K | — | View → |
| Sep 2, 2025 | Sep 2 8:37 PM | BARUCH TICHO | Proposed Sale | 10,844 | $19.76 | $214.3K | — | View → |
| Aug 29, 2025 | Aug 29 8:17 PM | EDWARD M KAYE | Proposed Sale | 61,885 | $19.77 | $1.2M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 8:33 PM | Arthur TzianabosDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:31 PM | Julie SmithDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:30 PM | LEVIN ARTHUR ADirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:29 PM | Adrian R. KrainerDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:27 PM | Edward M. Kaye MDDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:26 PM | Seth Loring HarrisonDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Jun 3, 2026 | Jun 5 8:24 PM | Jennifer BursteinDirector | Grant/Award | 17,786 | $29.46 | 17,786(D) | View → |
| Apr 3, 2026 | Apr 7 11:09 PM | Clare KahnDirector | Grant/Award | 30,782 | $32.79 | 30,782(D) | View → |
| Mar 19, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Option Exercise | 1,365 | $2.19 | 83,035(D) | View → |
| Mar 15, 2026 | Mar 17 9:26 PM | Jason HoittChief Patient Officer | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Mar 15, 2026 | Mar 17 9:26 PM | Thomas LeggettChief Financial Officer | Option Exercise | 14,750 | — | 44,250(D) | View → |
| Mar 15, 2026 | Mar 17 9:25 PM | Barry TichoCHIEF MEDICAL OFFICER | Option Exercise | 33,850 | — | 32,250(D) | View → |
| Mar 15, 2026 | Mar 17 9:24 PM | Edward M. Kaye MDDirector | Option Exercise | 61,750 | — | 52,500(D) | View → |
| Mar 15, 2026 | Mar 17 9:23 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Option Exercise | 25,475 | — | 36,000(D) | View → |
| Mar 10, 2026 | Mar 12 8:57 PM | Arthur TzianabosDirector, Interim Executive Chair | Option Exercise | 3,955 | $8.33 | 118,696(D) | View → |
| Feb 17, 2026 | Feb 19 9:25 PM | Barry TichoCHIEF MEDICAL OFFICER | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:24 PM | Ian F SmithDirector, Chief Executive Officer | Grant/Award | 322,000 | $31.09 | 129,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:22 PM | Thomas LeggettChief Financial Officer | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:21 PM | Jason HoittChief Patient Officer | Grant/Award | 120,000 | $31.09 | 48,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:20 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Grant/Award | 88,000 | $31.09 | 35,000(D) | View → |